REFERENCES
Abe T, Amaike Y, Shizu R, Takahashi M, Kano M, Hosaka T, et al.(2018). Role of YAP Activation in Nuclear Receptor CAR-Mediated
Proliferation of Mouse Hepatocytes. Toxicol Sci 165: 408-419.
Bhushan B, Stoops JW, Mars WM, Orr A, Bowen WC, Paranjpe S, et
al. (2019). TCPOBOP-Induced Hepatomegaly and Hepatocyte Proliferation
are Attenuated by Combined Disruption of MET and EGFR Signaling.
Hepatology 69: 1702-1718.
Blanco-Bose WE, Murphy MJ, Ehninger A, Offner S, Dubey C, Huang W,
et al. (2008). C-Myc and its target FoxM1 are critical downstream
effectors of constitutive androstane receptor (CAR) mediated direct
liver hyperplasia. Hepatology 48: 1302-1311.
Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, et
al. (2007). YAP1 increases organ size and expands undifferentiated
progenitor cells. Curr Biol 17: 2054-2060.
Chai X, Zeng S, & Xie W (2013). Nuclear receptors PXR and CAR:
implications for drug metabolism regulation, pharmacogenomics and
beyond. Expert Opin Drug Metab Toxicol 9: 253-266.
Costa RH, Kalinchenko VV, Tan YJ, & Wang IC (2005). The CAR nuclear
receptor and hepatocyte proliferation. Hepatology 42:1004-1008.
Dash AK, Yende AS, Kumar S, Singh SK, Kotiya D, Rana M, et al.(2014). The Constitutive Androstane Receptor (CAR): a nuclear receptor
in health and disease. J Endocrinol&Reprod 18: 59-74.
Deng YZ, Chen PP, Wang Y, Yin D, Koeffler HP, Li BJ, et al.(2007). Connective tissue growth factor is overexpressed in esophageal
squamous cell carcinoma and promotes tumorigenicity through
beta-catenin-T-cell factor/Lef signaling. J Biol Chem 282:36571-36581.
Eloranta JJ, & Kullak-Ublick GA (2005). Coordinate transcriptional
regulation of bile acid homeostasis and drug metabolism. Arch Biochem
Biophys 433: 397-412.
Fan F, He Z, Kong L-L, Chen Q, Yuan Q, Zhang S, et al. (2016).
Pharmacological targeting of kinases MST1 and MST2 augments tissue
repair and regeneration. Sci Transl Med 8.
Ganzenberg K, Singh Y, & Braeuning A (2013). The time point of
beta-catenin knockout in hepatocytes determines their response to
xenobiotic activation of the constitutive androstane receptor.
Toxicology 308: 113-121.
Geng Y, Whoriskey W, Park MY, Bronson RT, Medema RH, Li TS, et
al. (1999). Rescue of cyclin D1 deficiency by knockin cyclin E. Cell
97: 767-777.
Jiang Y, Feng D, Ma X, Fan S, Gao Y, Fu K, et al. (2019).
Pregnane X Receptor Regulates Liver Size and Liver Cell Fate by
Yes-Associated Protein Activation in Mice. Hepatology 69:343-358.
Jungermann K, & Katz N (1989). Functional specialization of different
hepatocyte populations. Physiol Rev 69: 708-764.
Kachaylo EM, Pustylnyak VO, Lyakhovich VV, & Gulyaeva LF (2011).
Constitutive androstane receptor (CAR) is a xenosensor and target for
therapy. Biochemistry (Mosc) 76: 1087-1097.
Kodama S, & Negishi M (2006). Phenobarbital confers its diverse effects
by activating the orphan nuclear receptor car. Drug Metab Rev
38: 75-87.
Kojic S, Nestorovic A, Rakicevic L, Belgrano A, Stankovic M, Divac
A, et al. (2010). A novel role for cardiac ankyrin repeat protein
Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein. Arch
Biochem Biophys 502: 60-67.
Konno Y, Negishi M, & Kodama S (2008). The roles of nuclear receptors
CAR and PXR in hepatic energy metabolism. Drug Metab Pharmacok
23: 8-13.
Kowalik MA, Saliba C, Pibiri M, Perra A, Ledda-Columbano GM, Sarotto
I, et al. (2011). Yes-associated protein regulation of adaptive
liver enlargement and hepatocellular carcinoma development in mice.
Hepatology 53: 2086-2096.
Labbe E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, et
al. (2007). Transcriptional cooperation between the transforming growth
factor-beta and wnt pathways in mammary and intestinal tumorigenesis.
Cancer Res 67: 75-84.
Li ZQ, Ding W, Sun SJ, Li J, Pan J, Zhao C, et al. (2012).
Cyr61/CCN1 Is Regulated by Wnt/beta-Catenin Signaling and Plays an
Important Role in the Progression of Hepatocellular Carcinoma. Plos One
7.
Luo Q, Kang Q, Si WK, Jiang W, Park JK, Peng Y, et al. (2004).
Connective tissue growth factor (CTGF) is regulated by Wnt and bone
morphogenetic proteins signaling in osteoblast differentiation of
mesenchymal stem cells. J Biol Chem 279: 55958-55968.
Mao SA, Glorioso JM, & Nyberg SL (2014). Liver regeneration. Transl Res
163: 352-362.
Min G, Kim H, Bae Y, Petz L, & Kemper JK (2002). Inhibitory cross-talk
between estrogen receptor (ER) and constitutively activated androstane
receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching
p160 coactivators. J Biol Chem 277: 34626-34633.
Oh SH, Swiderska-Syn M, Jewell ML, Premont RT, & Diehl AM (2018). Liver
regeneration requires Yap1-TGFbeta-dependent epithelial-mesenchymal
transition in hepatocytes. J Hepatol 69: 359-367.
Patel SH, Camargo FD, & Yimlamai D (2017). Hippo Signaling in the Liver
Regulates Organ Size, Cell Fate, and Carcinogenesis. Gastroenterology
152: 533-545.
Qatanani M, & Moore DD (2005). CAR, the continuously advancing
receptor, in drug metabolism and disease. Curr Drug Metab 6:329-339.
Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, et al. (2010).
Mammalian Mst1 and Mst2 kinases play essential roles in organ size
control and tumor suppression. Proc Natl Acad Sci U S A 107:1431-1436.
Sugatani J, Yamakawa K, Yoshinari K, Machida T, Takagi H, Mori M,
et al. (2002). Identification of a defect in the UGT1A1 gene promoter
and its association with hyperbilirubinemia. Biochem Bioph Res Co
292: 492-497.
Tschuor C, Kachaylo E, Limani P, Raptis DA, Linecker M, Tian Y, et
al. (2016). Constitutive androstane receptor (Car)-driven regeneration
protects liver from failure following tissue loss. J Hepatol
65: 66-74.
Wei P, Zhang J, Egan-Hafley M, Liang SG, & Moore DD (2000). The nuclear
receptor CAR mediates specific xenobiotic induction of drug metabolism.
Nature 407: 920-923.
Willson TM, & Kliewer SA (2002). PXR, CAR and drug metabolism. Nat Rev
Drug Discov 1: 259-266.